GLP-1

Schreiner MediPharm launches a GLP-1 pen label combining NFC, microtext and tamper evidence to fight counterfeit diabete...

Pharma fill-finish is forecast to reach $30.37bn by 2031 as biologics and GLP-1 drugs push CDMOs and brands into aseptic...